Blood use in patients undergoing repeat coronary artery bypass graft procedures: multivariate analysis

A W Bracey1, R Radovanĉević, B Radovanĉević

  • 1Department of Surgery, Texas Heart Institute, Houston, USA.

Transfusion
|October 1, 1995
PubMed

Insights

Patients undergoing repeat coronary artery bypass graft (CABG) surgery require significantly more blood transfusions than those undergoing primary CABG. This increased demand is linked to greater blood loss and longer cardiopulmonary bypass times.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Anesthesiology

Background:

  • Clinical consensus suggests repeat coronary artery bypass graft (CABG) operations necessitate greater blood transfusion volumes compared to primary CABG.
  • This study aimed to quantify this difference and identify contributing factors.

Purpose of the Study:

  • To compare blood transfusion requirements between primary and repeat CABG procedures.
  • To identify variables associated with increased transfusion needs in repeat CABG patients.

Main Methods:

  • Retrospective review of 196 primary CABG and 65 repeat CABG patients.
  • Data collected included transfusion volumes, preoperative/postoperative hemoglobin and hematocrit, cardiopulmonary bypass duration, graft details, and blood loss estimates.

Main Results:

  • Repeat CABG patients experienced 35% greater blood loss and required 75% more blood components.
  • Significantly higher transfusion rates for red cells (3.8 vs. 2.2 units), platelets (2.9 vs. 1.1 units), and fresh-frozen plasma (1.6 vs. 0.8 units) were observed in the repeat group.
  • Blood loss, prolonged cardiopulmonary bypass, lower preoperative hemoglobin, and aspirin use predicted red cell transfusion rates in repeat CABG patients.

Conclusions:

  • Repeat CABG surgery is associated with substantially higher blood transfusion rates.
  • Factors contributing to increased transfusion needs include microvascular bleeding, extended cardiopulmonary bypass, lower preoperative hemoglobin, and antiplatelet medication use.
Abstract